Bonumose
Bonumose produces tagatose, a low-calorie rare sugar sweetener, via a proprietary enzymatic platform that converts plant starch into scalable tagatose crystals. The company sells the ingredient to food and beverage manufacturers and a branded retail product direct-to-consumer via Amazon.
- Company typePrivate
- Founded2016
- HeadquartersCharlottesville, United States
- Headcount11–50
- GTM typeB2B and B2C
- OfferingHardware or Manufacturing
What Bonumose does
Bonumose, Inc. is a privately held food ingredient company headquartered in Charlottesville, Virginia, founded in 2016 by Ed Rogers (CEO) and Dr. Daniel Wichelecki (CSO). The company produces tagatose, a naturally occurring 'rare sugar' sweetener, using a proprietary enzymatic pathway that converts abundant plant starch (corn, wheat, cassava) into tagatose crystals at high yield and purity — a process Bonumose describes as the first to make tagatose scalable and affordable for mass-market use. The technology platform extends beyond tagatose to other rare ingredients targeted at food, supplements, animal feed, crop protection, and soil health. Tagatose carries an unusually strong regulatory profile: GRAS status, an FDA-approved dental caries reduction health claim, an EFSA-approved blood glucose health claim, NutraStrong Prebiotic Verified certification, and (as of April 2026) an FDA exemption from 'added sugar' labeling.
The company operates a hybrid go-to-market model. The primary B2B revenue stream is ingredient sales to food and beverage manufacturers for use in reformulated consumer products; the only named customer in the available data is San Martín (Greek yogurt with LGG probiotic). A secondary D2C channel sells Bonumose-branded Granulated Tagatose directly to consumers through Amazon for home cooking and baking use. Pricing for B2B contracts is not publicly disclosed and is presumed to be quote-based, while the consumer product is sold at unit retail pricing on Amazon. Strategic investors include Hershey and American Sugar Refining (both investing in February 2021), and the company signed a global co-development and scale-up agreement with Roquette in July 2024 to broaden production capacity and geographic reach. Manufacturing is conducted at a new commercial-scale facility opened in March 2023 in the Charlottesville area.
Cumulatively, Bonumose has raised approximately $49 million across six funding rounds between 2016 and 2023. Recognition includes World Economic Forum Technology Pioneer status (May 2022). Operational signals — facility commissioning, regulatory wins, a major strategic partnership with a top-tier global ingredient supplier, and ongoing capital deployment — point to a company transitioning from R&D and pilot scale into early commercial production, though no revenue figures are publicly disclosed and customer concentration outside of strategic partners is not visible.
Bonumose firmographics
Firmographics- Name
- Bonumose
- Legal name
- Bonumose, Inc.
- Website
- https://bonumose.com
- Company type
- Private
- Founded year
- 2016
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Bonumose produces tagatose, a low-calorie rare sugar sweetener, via a proprietary enzymatic platform that converts plant starch into scalable tagatose crystals. The company sells the ingredient to food and beverage manufacturers and a branded retail product direct-to-consumer via Amazon.
- Ownership category
- akta.pro rank
Bonumose industry classification
Industry- Product category
- Food Ingredients (Rare Sugar Sweetener)
- NAICS
- Sugar Manufacturing (31131), Sugar and Confectionery Product Manufacturing (3113)
- SIC
- Sugar & Confectionery Products (2060)
- akta.pro primary industry
- Rare Sugars (Allulose, Tagatose, Isomaltulose/Palatinose) (AFAJAAAK)
Keywords
Where Bonumose is headquartered
LocationHeadquarters
- HQ city
- Charlottesville
- HQ country
- United States
- HQ region
- North America
Offices2 records
Markets served
Bonumose business model
Business model- GTM type
- B2B and B2C
- Offering type
- Hardware or Manufacturing
- Cost components
- Supply Chain, Operations, Technology or R&D, Personnel, Infrastructure, Marketing or Sales
Revenue model
- B2B Ingredient Sales: Bonumose sells tagatose as an ingredient to food and beverage manufacturers for use in consumer products. This is the primary revenue stream, targeting globally-relevant industries including mainstream packaged foods.
- Consumer E-commerce (Amazon): Bonumose sells its own branded granulated tagatose product directly to consumers via Amazon, enabling individuals to purchase tagatose for home cooking, baking, and everyday recipes.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Unit Pricing | Pay-as-you-go | Amazon retail product for individual consumers |
Go-to-market motion2 records
Distribution channels2 records
Marketing channels7 records
Bonumose product offering
Product offeringCore offering
Bonumose produces tagatose, a rare sugar sweetener, using a proprietary enzymatic pathway that converts abundant plant starch (corn, wheat, cassava) into pure tagatose crystals at commercial scale. The company sells tagatose as a B2B ingredient to food and beverage manufacturers for use in consumer packaged goods, and as a finished branded Granulated Tagatose product to individual consumers through Amazon. Tagatose offers 90% of sugar's sweetness, glycemic index of 3, 38% of sugar's calories, and prebiotic and tooth-friendly benefits backed by FDA and EFSA health claims.
Product overview
Bonumose is a food ingredient company that produces tagatose, a rare sugar sweetener, using proprietary enzymatic technology to convert abundant plant starch into a scalable and affordable sugar alternative. The company offers its core ingredient product (Tagatose/Granulated Tagatose) both directly to food manufacturers as an ingredient and to consumers via Amazon. The portfolio includes the main Tagatose product along with value-added offerings like Brown Tagatose (a tagatose-molasses blend for baking) and a collection of recipes demonstrating tagatose's culinary applications. Tagatose serves as a direct sugar replacement in foods and beverages with proven health benefits including prebiotic properties, ultra-low glycemic impact, and FDA/EFSA-approved health claims.
Differentiator
Problem solved
Functional benefit
Products and services
- Granulated Tagatose A 1:1 sugar replacement sweetener produced via proprietary enzymatic conversion of plant starch into tagatose crystals. Glycemic index of 3, 38% of sugar's calories, prebiotic, tooth-friendly, with FDA and EFSA approved health claims. Sold as a bulk B2B ingredient to food and beverage manufacturers and as a branded 1 lb / 16 oz retail jar on Amazon for individual consumers for home cooking and baking.
- Brown Tagatose A tagatose-molasses blend offered as a value-added baking variant of Bonumose's core tagatose product, providing browning and flavor functionality for recipes.
Quantifiable outcome
- Glycemic index of 3 (vs. 68 for table sugar and 100 for glucose)
- +3 more outcomes
Companies that use Bonumose
Customer profileNamed customers1 record
Segments2 records
Ideal customer profiles2 records
Bonumose technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature2 records
Bonumose partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- RoquettecoreRoquette and Bonumose signed a global cooperation agreement in July 2024 to enhance the production of tagatose, a natural sweetener with proven health benefits. The partnership focuses on technological and scale-up development to meet growing demand for healthier sugar alternatives as food formulators increasingly adopt natural sweeteners.
Scale indicators2 records
Recent moves7 records
Expansion highlights6 records
Bonumose competitors and assessment
Company assessmentDirect peers
- Tate & Lyle: Global food ingredient manufacturer producing allulose (Dolcia Prima Allulose) and other specialty sweeteners. Tate & Lyle competes head-to-head with Bonumose in the rare-sugar/low-calorie sweetener category serving CPG and foodservice customers.
- Ingredion: Global ingredient solutions company producing Astraea Allulose and a broad portfolio of sweeteners and starches. Ingredion directly competes with Bonumose for food and beverage manufacturer accounts seeking rare-sugar and sugar-reduction solutions.
- Matsutani Chemical: Japanese specialty ingredient manufacturer and the largest producer of allulose (a competing rare sugar) globally. Matsutani is a direct competitor in the rare-sugar sweetener category targeting food and beverage manufacturers seeking low-calorie alternatives to sugar.
Broad incumbents
- DSM-Firmenich: Global ingredients company combining nutrition, health, and flavors expertise, including enzyme technology and sweetener solutions. DSM-Firmenich competes with Bonumose in the broader food ingredient space and has the R&D capability to develop alternative tagatose pathways.
- Roquette: Global leader in plant-based ingredients (starches, polyols including sorbitol, mannitol, xylitol) and Bonumose's strategic partner for tagatose scale-up. Roquette's polyol sweetener portfolio places it in direct competition with Bonumose in food/beverage ingredient markets.
- ADM: Global food ingredient and agricultural processor with a sweeteners and starches business serving food, beverage, and industrial customers. ADM's scale and ingredient breadth create overlapping competition with Bonumose in CPG sweetener markets.
- Cargill: One of the largest global food ingredient and agricultural commodity companies, producing sweeteners, starches, and specialty food ingredients. Cargill's scale and customer relationships in food manufacturing make it both a potential partner and competitor for Bonumose.
Emerging players
- SweeGen: Specialty sweetener company focused on next-generation, nature-based sweeteners including stevia and rare sugars. SweeGen competes with Bonumose for B2B food and beverage accounts seeking reduced-sugar ingredient solutions.
- Conagen: Biotechnology company using fermentation to produce rare and specialty ingredients including sweeteners. Conagen's bioproduction capabilities position it as a potential competitor or partner in the rare-sugar space where Bonumose operates.
- Amyris: Synthetic biology company producing fermentation-derived ingredients including sugar alternatives. Amyris's fermentation technology represents an alternative production pathway for rare sugars and competes with Bonumose's enzymatic approach.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
Bonumose social profiles
Digital presenceBonumose compliance and trust
Trust signalCompliance4 records
Bonumose financial estimates
Financial estimateRevenue estimate
Valuation estimate
Bonumose leadership team
Management profileNumber of profiles
Profiles2 records
Bonumose funding detail
Funding detailFunding overview
Funding rounds6 records
Investors6 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Bonumose M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Bonumose
What does Bonumose do?
Bonumose produces tagatose, a rare sugar sweetener, using a proprietary enzymatic pathway that converts abundant plant starch (corn, wheat, cassava) into pure tagatose crystals at commercial scale. The company sells tagatose as a B2B ingredient to food and beverage manufacturers for use in consumer packaged goods, and as a finished branded Granulated Tagatose product to individual consumers through Amazon. Tagatose offers 90% of sugar's sweetness, glycemic index of 3, 38% of sugar's calories, and prebiotic and tooth-friendly benefits backed by FDA and EFSA health claims.
Is Bonumose a public or private company?
Bonumose is a private company. It is classified as venture growth investor backed and is currently operating.
When was Bonumose founded?
Bonumose was founded in 2016. It employs 11 to 50 people.
Where is Bonumose based?
Bonumose is headquartered in Charlottesville, United States, in the North America region.
How does Bonumose make money?
Two revenue lines are on record. B2B Ingredient Sales are the primary driver. The others are consumer E-commerce (Amazon).
Who are Bonumose's main competitors?
Direct peers on record are Tate & Lyle, Ingredion and Matsutani Chemical. Broad incumbents are DSM-Firmenich, Roquette, ADM and Cargill. Emerging players are SweeGen, Conagen and Amyris.
Does Bonumose have an API?
No public API is recorded for Bonumose.
What industry is Bonumose in?
Bonumose's product category is Food Ingredients (Rare Sugar Sweetener). Its primary akta.pro industry code is AFAJAAAK, Rare Sugars (Allulose, Tagatose, Isomaltulose/Palatinose). Its NAICS code is 31131 and its SIC code is 2060.